You are here

Article info

Article menu
Download PDFPDF
Autoimmune inflammation
08.13 Understanding aberrant il-6 mediated cd4+ t-cell signalling in early rheumatoid arthritis

Authors

  • Laura Ridgley 1Arthritis Research UK, Rheumatoid Arthritis Pathogenesis Centre of Excellence (RACE)2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Amy Anderson 1Arthritis Research UK, Rheumatoid Arthritis Pathogenesis Centre of Excellence (RACE)2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Andrew Skelton 2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK3Bioinformatics Support Unit, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • David Young 2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • John Isaacs 1Arthritis Research UK, Rheumatoid Arthritis Pathogenesis Centre of Excellence (RACE)2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Ruaidhrí Carmody 1Arthritis Research UK, Rheumatoid Arthritis Pathogenesis Centre of Excellence (RACE)3Bioinformatics Support Unit, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles
  • Arthur Pratt 1Arthritis Research UK, Rheumatoid Arthritis Pathogenesis Centre of Excellence (RACE)2Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, UK PubMed articlesGoogle scholar articles

Citation

Ridgley L, Anderson A, Skelton A, et al
08.13 Understanding aberrant il-6 mediated cd4+ t-cell signalling in early rheumatoid arthritis
Annals of the Rheumatic Diseases 2017;76:A80.

Publication history

  • First published March 1, 2017.
Online issue publication 
January 09, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© 2017, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions